These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12787763)

  • 1. T-cell effector mechanisms: gammadelta and CD1d-restricted subsets.
    Jameson J; Witherden D; Havran WL
    Curr Opin Immunol; 2003 Jun; 15(3):349-53. PubMed ID: 12787763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
    Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
    J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD1-specific T cells in microbial immunity.
    Gumperz JE; Brenner MB
    Curr Opin Immunol; 2001 Aug; 13(4):471-8. PubMed ID: 11498304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted gamma delta T cells.
    Russano AM; Agea E; Corazzi L; Postle AD; De Libero G; Porcelli S; de Benedictis FM; Spinozzi F
    J Allergy Clin Immunol; 2006 May; 117(5):1178-84. PubMed ID: 16675349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
    Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
    J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.
    Liu W; Huber SA
    Virol J; 2011 Jan; 8():32. PubMed ID: 21255407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.
    Champagne E; Martinez LO; Vantourout P; Collet X; Barbaras R
    Immunol Res; 2005; 33(3):241-55. PubMed ID: 16462001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?
    Gumperz JE
    J Leukoc Biol; 2004 Aug; 76(2):307-13. PubMed ID: 15123775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.
    Benlagha K; Bendelac A
    Semin Immunol; 2000 Dec; 12(6):537-42. PubMed ID: 11145859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
    Amanuma R; Nakajima T; Yoshie H; Yamazaki K
    J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
    Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
    PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunology of CD1- and MR1-Restricted T Cells.
    Mori L; Lepore M; De Libero G
    Annu Rev Immunol; 2016 May; 34():479-510. PubMed ID: 26927205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis.
    Ho LP; Urban BC; Thickett DR; Davies RJ; McMichael AJ
    Lancet; 2005 Mar 19-25; 365(9464):1062-72. PubMed ID: 15781102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic science for the clinician 35: CD1, invariant NKT (iNKT) Cells, and gammadelta T-cells.
    Sigal LH
    J Clin Rheumatol; 2005 Dec; 11(6):336-9. PubMed ID: 16371809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective identification of Valpha14i T cells using slide-immobilized, CD1d-antigen complexes.
    Zullo AJ; Brutkiewicz RR; Taparowsky EJ
    J Immunoassay Immunochem; 2006; 27(3):207-12. PubMed ID: 16827223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
    Braza MS; Klein B
    Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.
    Grubor-Bauk B; Simmons A; Mayrhofer G; Speck PG
    J Immunol; 2003 Feb; 170(3):1430-4. PubMed ID: 12538704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses.
    Exley MA; Tahir SM; Cheng O; Shaulov A; Joyce R; Avigan D; Sackstein R; Balk SP
    J Immunol; 2001 Nov; 167(10):5531-4. PubMed ID: 11698421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.